One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort Study
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 1500
Summary
- Conditions
- Arthritis, Psoriatic
- Arthritis Rheumatoid
- Colitis Ulcerative
- Crohn's Disease
- Spondylitis, Ankylosing
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 6 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03662919
- Collaborators
- Not Provided
- Investigators
- Study Director: Medical Director Biogen